CSI Market
Sign In | Register

Oragenics Inc (OGEN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OGEN Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Oragenics Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-4.73
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.03
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-0.02
Stock Issued For Purchase-
Increase Decrease In Operating Lease Right Of Use Assets-
Stockbased Compensation Recapture Expense-0.09
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives and Commodity Contracts0.00
Increase (Decrease) in Accrued Interest Receivable, Net0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.26
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.05
Discontinued operations0.00
Net Cash flow from Operating Activities-4.39
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale of Short-term Investments4.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities4.00
Financing Activities
Short-term debt Net-0.23
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.08
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Cash And Cash Equivalents Period Increase Decrease Discontinuing Operations-
Proceeds From Payment Of Stock Subscription Receivable-
Proceeds From Issuance Of Convertible Preferred Stock And Warrants-
Net Proceeds From Exercise Of Common Stock Warrants-
Net Proceeds From Issuance Of Common Stock And Warrants-
Net Proceeds From Issuance Of Common Stock Convertible Preferred Stock And Warrants-
Proceeds From Issuance Of Common Stock For Warrant Exercise-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.15
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.39
Total Cash Flow-0.54
4 historic quarters locked

Sign in to unlock the full Oragenics Inc cash flow history.

Sign In Create Free Account

About Oragenics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-037749

Figures are derived from filed reports and may be restated. Historical data is subject to revision.